The antiviral combination of nirmatrelvir and ritonavir (brand name Paxlovid) is an effective treatment for people with COVID ...

A new study from researchers at Weill Cornell Medicine-Qatar (WCM-Q) reveals how the SARS-CoV-2 virus evolved from initially ...

Chitosan, a naturally occurring polysaccharide derived from chitin, has demonstrated significant potential as an antiviral ...

A new study found severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was associated with the rapid growth ...

The SARS-CoV-2 spike (S) protein mediates its ... PTPN2 deficiency increases ACE2 expression and viral entry through a STAT1-dependent mechanism. STAT1/3 are PTPN2 substrates that are directly ...

However, the mechanisms through which these anti-ACE2 antibodies are induced during SARS-CoV-2 infection are unclear. In this study, we confirmed the increase in antibodies against ACE2 in patients ...

On Wednesday, January 22, 2025, Dr. Danielle Beckman, Project Scientist at the California National Primate Research Center, USA, will give a seminar on “Sars-CoV-2 neuroinvasive potential and ...

B cell production of IgA was shown to be of significant influence in mediating mucosal immunity as the first part of the defense mechanism and in the development of nasal vaccines. Here, we interpret ...

Titania nanoparticles damage enveloped viruses by directly binding with membrane phospholipids – a previously unknown mode of antiviral action ...

The outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in late 2019 caused coronavirus ... The pathophysiological mechanism of vaccine-associated SAT is still not ...